<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04413565</url>
  </required_header>
  <id_info>
    <org_study_id>08.12.2016-71306642-050.01.04</org_study_id>
    <nct_id>NCT04413565</nct_id>
  </id_info>
  <brief_title>Infection Rate of One-Stage Bilateral TKR - One Surgeon Sequential vs. Two Surgeon Simultaneous: A Randomized Controlled Study</brief_title>
  <official_title>Infection Rate of One-Stage Bilateral TKR - One Surgeon Sequential vs. Two Surgeon Simultaneous: A Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bezmialem Vakif University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bezmialem Vakif University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of bilateral total knee replacements (TKR) is increasing with the number of patients&#xD;
      with bilateral end-stage knee osteoarthritis. Bilateral TKR can be performed in three&#xD;
      different ways: single-stage, two-team simultaneous bilateral TKR (two surgeons bilateral&#xD;
      TKR); single-stage, a sequential bilateral TKR (single surgeon bilateral TKR); and two-stage&#xD;
      bilateral TKR. Periprosthetic joint (PJI) infections are serious complications after TKR that&#xD;
      negatively affect the aimed outcome, decrease patient satisfaction, and increase morbidity&#xD;
      and mortality. The incidence of PJI is 1-2% and the number of cases is projected to grow as&#xD;
      the indications for TKR continue to increase. Investigators will prospectively compare the&#xD;
      incidence of periprosthetic joint infection between groups.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      924 knees (462 participants) will prospectively be randomized into 2 groups: two surgeons&#xD;
      bilateral TKA and single surgeon bilateral TKA. While 2 surgeons will perform simultaneous&#xD;
      total knee arthroplasty in the two surgeons' bilateral TKA group, one surgeon will perform&#xD;
      sequentially in the single surgeon bilateral TKA group. The primary outcome is to compare the&#xD;
      incidence of PJI between the groups. Secondary, logistic regression use to estimate the&#xD;
      effect of two surgeons bilateral TKA and single surgeon bilateral TKA on the likelihood of a&#xD;
      patient being infected.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 8, 2016</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Infection incedence</measure>
    <time_frame>90 days</time_frame>
    <description>Early infection rates</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">413</enrollment>
  <condition>Infection Joint</condition>
  <condition>Joint Infection</condition>
  <condition>Arthroplasty Complications</condition>
  <arm_group>
    <arm_group_label>Two surgeon bilateral TKA group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 surgeons will perform simultaneous total knee arthroplasty in this group.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Single surgeon bilateral TKA group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>One surgeon will perform sequentially tptal knee arthroplasty in this group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Simultaneous bilateral total knee arthroplasty</intervention_name>
    <description>Two surgeon bilateral TKA group</description>
    <arm_group_label>Two surgeon bilateral TKA group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sequenced bilateral TKA</intervention_name>
    <description>Single surgeon bilateral TKA group</description>
    <arm_group_label>Single surgeon bilateral TKA group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Primary bilateral knee osteoarthritis with refractory to conservative treatment Patients&#xD;
        who accept participation in the research and the randomization&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        no history of malignancy without severe extra-articular deformities&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bezmialem Vakif University</name>
      <address>
        <city>Istanbul</city>
        <state>Fatih</state>
        <zip>34000</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Orkhan Aliyev</last_name>
      <phone>05059917419</phone>
      <email>orkhanaliyev@outlook.com.tr</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 29, 2020</study_first_submitted>
  <study_first_submitted_qc>May 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 4, 2020</study_first_posted>
  <last_update_submitted>May 29, 2020</last_update_submitted>
  <last_update_submitted_qc>May 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bezmialem Vakif University</investigator_affiliation>
    <investigator_full_name>Orkhan Aliyev</investigator_full_name>
    <investigator_title>MD, Resident Doctor in Orthopaedic Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

